Finasteride is used to treat symptoms of benign prostatic hypertrophy (BPH), such as frequent and difficult urination. Besides this, it is also used to treat male pattern hair loss.
Finasteride contains Finasteride, which works by blocking the action of male hormones that cause prostate enlargement and hair loss. Thereby, it helps treat BPH and male pattern hair loss.
In some cases, Finasteride may cause low sexual desire, impotence (erectile dysfunction), abnormal ejaculation, or trouble having an orgasm. Most of these side effects of Finasteride may not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
Do not take Finasteride if you are allergic to any of its components. Finasteride is not intended for use in women and children. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.
Treatment of benign prostatic hypertrophy (BPH) and male pattern hair loss.
Finasteride belongs to a class of medicines called 5-alpha-reductase inhibitors used to treat symptoms of benign prostatic hypertrophy (BPH) in men with enlarged prostate. It also may decrease the need for prostate surgery. Additionally, it is also used to treat male pattern hair loss. Finasteride works by blocking the action of male hormones that cause the prostate to enlarge and hair loss.
• Finasteride can be taken with or without food. • It is usually taken once daily at the same time each day or as prescribed by your doctor. • Swallow Finasteride as a whole with a glass of water. • Do not crush, chew, or break it.
Store in a cool and dry place away from sunlight
Thereby, Finasteride helps treat benign prostatic hypertrophy (BPH) and male pattern hair loss. 5-alpha-reductase inhibitorsblocking the effects of male hormones on the prostate:
How It Works
Finasteride contains Finasteride which helps treat symptoms of benign prostatic hypertrophy (BPH) and male pattern hair loss.
Positories of Finasteride are available to treat BPH and male pattern hair loss.
Side Effects
“
”
5-alpha-reductase inhibitorsblock the effects of male hormones on the prostate and hair loss. However, it is important to note that Finasteride may cause other side effects such as low sexual desire, impotence, and thinning of hair as well. Please consult your doctor for safe usage of Finasteride.
The most common side effects of Proscar include a decreased interest in sexual intercourse, inability to have or keep an erection, or a loss in sexual ability, desire, drive or performance. Talk to your doctor or a healthcare professional if symptoms persist or are severe.
You should contact your doctor immediately if you experience any of the following symptoms:
While rare, these symptoms require immediate medical attention. This is not a complete list of side effects associated with finasteride. Studies have shown that finasteride can increase your risk of developing breast cancer or high-grade prostate cancer, which spreads and grows more rapidly than other types of prostate cancer.
Studies have also shown that Proscar can affect the results of the prostate-specific antigen (PSA) test, which may be used to detect prostate cancer. Be sure to tell your healthcare provider that you are taking finasteride so that they are aware of any medication interference with PSA testing.
Proscar is only for use in men and can cause birth defects in pregnant women. If you are breastfeeding, pregnant, or plan on becoming pregnant and touch crushed or broken Proscar tablets, you should wash your hands and call your doctor right away.
Read More About What You Use For Prostate Cancer On On. ().Finasteride is not recommended for use in women. It is not recommended for use in children. It is not recommended for use in adults. Your doctor will tell you whether finasteride is right for you. Do not discontinue any medication without consulting your doctor.
Take finasteride by mouth with a glass of water. Finasteride may be taken with or without food, but it is better to take it at a fixed time. The tablets should be swallowed whole. If a piece of bread is swallowed, use a heavy or sweet tongue. If a table leg is swallowed, your healthcare provider will watch you as you take the tablets. Do not crush, cut, or cut the bread, as this will delay the medication's absorption in your body.
Finasteride may make it through the kidneys, prostate, and possibly other medicines before being diagnosed with male pattern hair loss. However, it is not recommended for use in women. Talk to your doctor if you have any questions about how to manage male pattern hair loss or if you are concerned about your hair loss.
A small number of men will experience side effects of finasteride, including:
If you are taking finasteride because you are experiencing side effects, your healthcare provider may be able to tell you about a different drug. For example, it could be a drug that interacts with finasteride that affects hair growth.
Some medications have different side effects. For example, finasteride has been shown to increase the risk of developing:
Some studies have found isosorbide mononitrate to be slightly more effective than finasteride for male pattern hair loss. However, finasteride is only used to treat male pattern hair loss in men. Finasteride is primarily used to treat benign prostatic hyperplasia (BPH) and the condition " pattern hair loss."
It is unknown if finasteride is safe for women. It is not known if finasteride is safe for women. Discuss with your healthcare provider if you ever had any changes in your menstrual pattern.
Finasteride can only be used in men.
Objectives:We examined the effectiveness of finasteride and dutasteride for the treatment of benign prostatic hyperplasia (BPH) in men with androgenetic alopecia. Patients with BPH were treated with either finasteride or dutasteride. The mean change in prostatic volume at 12 months of follow-up was -0.5 vs. -0.2 ml/cm2 at baseline, -0.2 vs. -0.2 ml/cm2 at follow-up, and -0.6 vs. -0.7 ml/cm2 at baseline. The mean change in urinary flow rate (QTc) was -0.7 vs. -0.2 s/hr at 12 months. There were no significant differences in the proportion of patients with prostate specific antigen (PSA) above the reference range between the two treatment groups (P = 0.09). Results from a total of 8,500 men (aged 18 to 50 years with no evidence of BPH) treated with finasteride, dutasteride, or placebo were analyzed. Prostatic volume was decreased by 55% at 12 months (P < 0.001) but the increase in urinary flow rate was not statistically significant (P = 0.07). At 12 months, the mean QTc of the two treatment groups was -0.3 and -0.4 s/hr, respectively. The mean change in urinary flow rate was -0.8 vs. -0.4 s/hr at 12 months, and was statistically significant (-0.5 vs. -0.3 s/hr at 12 months). The mean change in prostate volume was -0.3 vs. -0.3 ml/cm2 at 12 months (P = 0.001). The mean change in QTc at 12 months was -0.7 vs. -0.2 ml/cm2 at 12 months (P = 0.09). There was no difference in the proportion of patients with BPH treated with finasteride and dutasteride over the placebo group. There was no significant difference between the two treatment groups in terms of urinary flow rate.
Patients and methods:A total of 10,072 patients (aged 18 to 50 years with no evidence of BPH) with BPH, and 10,945 men with benign prostatic hyperplasia (BPH) were treated with finasteride and dutasteride at baseline and at 12 months. Finasteride, dutasteride, and placebo were given as monotherapy or in combination. Dutasteride and placebo were given as monotherapy or in combination. The mean change in prostatic volume at 12 months was -0.5 ml/cm2 at baseline, -0.6 ml/cm2 at 12 months, and -0.7 ml/cm2 at 12 months. At 12 months, the change in urinary flow rate was -0.7 ml/hr at 12 months, and was statistically significant (P < 0.001). The change in prostate volume at 12 months was -0.2 ml/hr at 12 months, and was statistically significant (P = 0.07). The mean change in QTc was -0.3 vs. -0.3 ml/hr at 12 months, and was statistically significant (-0.5 vs. -0.4 ml/hr at 12 months). The mean change in urinary flow rate was -0.7 vs. -0.2 s/hr at 12 months (P = 0.05). There was no significant difference between treatment groups in terms of prostate specific antigen (PSA) levels at 12 months.
Results:The mean change in urinary flow rate was -0.7 ml/hr at 12 months, and was statistically significant (-0.5 vs. -0.3 ml/hr at 12 months). The change in urinary flow rate was significantly different between finasteride and dutasteride (P = 0.001). The change in QTc was -0.5 vs. -0.3 ml/hr at 12 months (P = 0.01).
Conclusions:The clinical effectiveness of finasteride and dutasteride in the treatment of benign prostatic hyperplasia in men with androgenetic alopecia was evaluated by the change in urinary flow rate. The changes in urinary flow rate were statistically significant compared with the change in QTc, which was a small but clinically important decrease (P < 0.001).
Treatment with finasteride and dutasteride for BPH: a population-based cohort study.Salt Composition in both
Salt Composition
Finasteride 1mg(same for both)
You Searched
Strip of 10 tablets
We only sell the best substitute from top brands
Our Recommendation
Finaworth 1mg Tablet 10s
432+ Customers trust this
WHO GMP Certified
Marketed by
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Yes NOWe will match your criteria for delivery and schedule delivery for your selected delivery address.
Accepting criteria:Delivery date is 12-14-2015
At this time, we only sell the best brand & generic products as per demand. It is solely for personal use of customers. No support is offered by the manufacturer to comment on product alternatives without the prior's approval.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
UnitHealthylife provides medical information for your convenience. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the manufacturer's website or email [email protected].
Stade de France Pharmacy